German Biotech BioNTech Locks in $270M Series A Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Company previously completed a seed round fundraising in 2008 concurrent with its founding. Source: BioSpace You Might Also Like Magenta Therapeutics and Heidelberg Pharma Team Up for Bone Marrow Transplants March 5, 2018 Allergan Could Bank $1B by Unloading Its Anti-Infectives Biz January 17, 2018 Phenomenex Announces Direct Sales And Support In Switzerland September 5, 2017